Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 1,014,000 | 1,115,000 | 1,216,000 | 1,339,000 | 1,254,000 |
| Cost of Goods | 97,000 | 95,000 | 104,000 | 94,000 | 81,000 |
| Gross Profit | 917,000 | 1,020,000 | 1,112,000 | 1,245,000 | 1,173,000 |
| Operating Expenses | 571,000 | 458,000 | 417,000 | 361,000 | 301,000 |
| Operating Income | 346,000 | 562,000 | 695,000 | 884,000 | 872,000 |
| Interest Expense | 61,000 | 1,000 | 0 | 0 | 0 |
| Pre-tax Income | 285,000 | 561,000 | 695,000 | 884,000 | 872,000 |
| Income Tax | 57,000 | 158,000 | 206,000 | 277,000 | 258,000 |
| Net Income Continuous | 228,000 | 403,000 | 489,000 | 607,000 | 614,000 |
| Net Income | $228,000 | $403,000 | $489,000 | $607,000 | $614,000 |
| EPS Basic Total Ops | 1.60 | 2.80 | 3.40 | N/A | N/A |
| EPS Basic Continuous Ops | 1.59 | 2.80 | 3.40 | N/A | N/A |
| EPS Diluted Total Ops | 1.55 | 2.80 | 3.40 | N/A | N/A |
| EPS Diluted Continuous Ops | 1.56 | 2.78 | 3.38 | N/A | N/A |
| EBITDA(a) | $378,000 | $588,000 | $723,000 | $911,000 | $897,000 |